Page 104 - Genomic Medicine in Emerging Economies

References 93

Alvarez, C., Tapia, T., Perez-Moreno, E., Gajardo-Meneses, P., Ruiz, C., Rios, M., et al., 2017. BRCA1
and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast
cancer families in Chile. Oncotarget 8 (43), 74233–74243.
Álvarez, K., de la Fuente, M., Orellana, P., Wielandt, A.M., Heine, C., Suazo, C., et al., 2012.
Mutación homocigota en la línea germinal del gen MUTYH en una paciente chilena con poli-
posis adenomatosa familiar. Revista médica de Chile. scielocl 140, 1457–1463.
Ashton-Prolla, P., Seuanez, H.N., 2016. The Brazilian Hereditary Cancer Network: historical aspects
and challenges for clinical cancer genetics in the public health care system in Brazil. Genet.
Mol. Biol. 39 (2), 163–165.
Ashton-Prolla, P., Vargas, F.R., 2014. Prevalence and impact of founder mutations in hereditary
breast cancer in Latin America. Genet. Mol. Biol. 37 (1 Suppl. 1), 234–240.
Berg, A.O., Armstrong, K., Botkin, J., Calonge, N., Haddow, J., Hayes, M., et al., 2009. Recom-
mendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed
individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch
syndrome in relatives. Genet. Med. 11 (1), 35–41.
Bertario, L., Russo, A., Sala, P., Varesco, L., Giarola, M., Mondini, P., et al., 2003. Multiple approach
to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J.
Clin. Oncol. 21 (9), 1698–1707.
Bisgaard, M.L., Bülow, S., 2006. Familial adenomatous polyposis (FAP): genotype correlation to
FAP phenotype with osteomas and sebaceous cysts. Am. J. Med. Genet. 140 (A(3)), 200–204.
Boland, C.R., Troncale, F.J., 1984. Familial colonic cancer without antecedent polyposis. Ann. Int.
Med. 100 (5), 700–701.
Bonilla, C., Bertoni, B., Hidalgo, P.C., Artagaveytia, N., Ackermann, E., Barreto, I., et al., 2015. Breast
cancer risk and genetic ancestry: a case-control study in Uruguay. BMC Womens Health 15 (1), 11.
Cajal, A.R., Pinero, T.A., Verzura, A., Santino, J.P., Solano, A.R., Kalfayan, P.G., et al., 2016. Founder
mutation in Lynch syndrome. Medicina (B Aires) 76 (3), 180–182.
Carneiro da Silva, F., Ferreira, J.R., de, O., Torrezan, G.T., Figueiredo, M.C.P., Santos ÉMM, Nak-
agawa, W.T., et al., 2015. Clinical and molecular characterization of Brazilian patients sus-
pected to have Lynch syndrome. PLoS One 10 (10), e0139753.
Carraro, D.M., Koike Folgueira, M.A.A., Garcia Lisboa, B.C., Ribeiro Olivieri, E.H., Vitorino Krepis-
chi, A.C., de Carvalho, A.F., et al., 2013. Comprehensive analysis of BRCA1BRCA2 and TP53
germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
PLoS One 8 (3).
Caspari, R., Friedl, W., Mandl, M., Möslem, G., Kadmon, M., Knapp, M., et al., 1994. Familial
adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 343
(8898), 629–632.
Caspari, R., Olschwang, S., Friedl, W., Mandl, M., Boisson, C., Böker, T., et al., 1995. Familial
adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (chrpe) associated
with APC mutations beyond codon 1444. Hum. Mol. Genet. 4 (3), 337–340.
Castro-Mujica Mdel, C., Sullcahuaman-Allende, Y., Barreda-Bolanos, F., Taxa-Rojas, L., 2014. Inher-
ited colorectal cancer predisposition syndromes identified in the Instituto Nacional de Enfer-
medades Neoplasicas (INEN), Lima, Peru. Rev. Gastroenterol. Peru 34 (2), 107–114.
Castro-Mujica, M.D.C., Barletta-Carrillo, C., Acosta-Aliaga, M., Montenegro-Garreaud, X., 2016.
Lynch syndrome Muir Torre variant: 2 cases. Rev. Gastroenterol. Peru 36 (1), 81–85.
Cheadle, J.P., Sampson, J.R., 2003. Exposing the MYtH about base excision repair and human
inherited disease. Hum. Mol. Genet. 12, Spec No (2):R159-65.
Chen, S., Parmigiani, G., 2007. Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 25
(11), 1329–1333.